“Treatment”的搜索结果，显示 631-640 项，共有 18078 项

1. 肾病和高血压- 临床试验- 妙佑医疗国际

   SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...

2. 血液科- 临床试验- 妙佑医疗国际

   Tafasitamab, Lenalidomide And Venetoclax For The Treatment Of Relapsed Or Refractory Mantle Cell Lymphoma. Rochester, Minn. The purpose of this study is to ...

3. 放射科- 临床试验- 妙佑医疗国际

   The purpose of this trial is to study the effect of lutetium Lu 177 dotatate compared to the usual treatment (everolimus) in treating patients with ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... treatment arm-specific definition. Eligible participants with mCRC will be enrolled into specific treatment arms based on their biomarker assay results.

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... treatment (refractory). A Study To Evaluate Azacitidine Plus Venetoclax Induction Chemotherapy To Treat Acute Myeloid Leukemia Patients For T-cell Directed ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... treatment, in HPV negative patients or in normal controls). A Study Of Endometrial Cancer Testing With Vaginal And Endometrial Cell Samples. Scottsdale ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Efineptakin alfa (NT-I7) Plus Pembrolizumab for the Treatment of Recurrent Glioblastoma. Rochester, Minn. The purpose of this study is to determine the response ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... treatment of rhabdomyosarcoma. Additionally, to find out how well patients ... treatment. Finally, this study examines the effect of therapy ...

9. 脑肿瘤项目- 临床试验- 妙佑医疗国际

   The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, and ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... treatment cycles (R-CHOP-21) and CC99282 in combination with R-CHOP-21 in subjects with previously untreated, high risk (International Prognostic Index [IPI] ...